These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 30821463

  • 21. Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131 I-NaI treatments of differentiated thyroid cancer.
    Mínguez P, Flux G, Genollá J, Delgado A, Rodeño E, Sjögreen Gleisner K.
    Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan.
    Blakkisrud J, Løndalen A, Martinsen AC, Dahle J, Holtedahl JE, Bach-Gansmo T, Holte H, Kolstad A, Stokke C.
    J Nucl Med; 2017 Jan; 58(1):48-54. PubMed ID: 27493270
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.
    Eppard E, de la Fuente A, Benešová M, Khawar A, Bundschuh RA, Gärtner FC, Kreppel B, Kopka K, Essler M, Rösch F.
    Theranostics; 2017 Jan; 7(18):4359-4369. PubMed ID: 29158832
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics.
    Deberle LM, Benešová M, Becker AE, Ratz M, Guzik P, Schibli R, Müller C.
    Bioconjug Chem; 2021 Aug 18; 32(8):1617-1628. PubMed ID: 34251183
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177Lu-Dendrimer-AuNP-Folate-Bombesin Nanoprobe Located Inside Cancer Cells.
    Mendoza-Nava H, Ferro-Flores G, Ramírez FM, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Luna-Gutiérrez M, Isaac-Olivé K.
    Mol Imaging; 2017 Jan 01; 16():1536012117704768. PubMed ID: 28654384
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A, Fendler WP, Kratochwil C, Brunegraf A, Gosewisch A, Gildehaus FJ, Tritschler S, Stief CG, Kopka K, Haberkorn U, Bartenstein P, Böning G.
    Eur J Nucl Med Mol Imaging; 2016 Jan 01; 43(1):42-51. PubMed ID: 26318602
    [Abstract] [Full Text] [Related]

  • 33. Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment.
    Handayani W, Chantadisai M, Phromphao B, Noipinit N, Pasawang P, Khamwan K.
    Ann Nucl Med; 2024 Nov 01; 38(11):884-893. PubMed ID: 39023826
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tumoral fibrosis effect on the radiation absorbed dose of (177)Lu-Tyr(3)-octreotate and (177)Lu-Tyr(3)-octreotate conjugated to gold nanoparticles.
    Azorín-Vega EP, Zambrano-Ramírez OD, Rojas-Calderón EL, Ocampo-García BE, Ferro-Flores G.
    Appl Radiat Isot; 2015 Jun 01; 100():96-100. PubMed ID: 25305748
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicity.
    Kamaldeep, Thapa P, Wanage G, Tervankar S, Kaisar S, Ranade R, Basu S, Das T, Banerjee S.
    Nucl Med Commun; 2021 Oct 01; 42(10):1076-1084. PubMed ID: 34528928
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.